logo

IPHA

Innate Pharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
4.07 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Trend Analysis of IPHA
  • Based on a composite score of 4.07/10, we rate IPHA as a Netural. Our analysis breaks down into 1.70/10 for Fundamentals, 4.62/10 for Technicals, and 4.99/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is IPHA undervalued or overvalued?
Technical Analysis of IPHA?
Is money flowing into or out of IPHA?